Alameda Healthcare to operate EAEA’s oncology unit in a USD9 million Nasr City partnership

EGYPT—Alameda Healthcare Group, a leading private healthcare provider in Egypt, has partnered with the Egyptian Atomic Energy Authority (EAEA) to manage and operate the Radiotherapy Treatment, Training, and Research Unit in Nasr City.

This collaboration represents a significant public-private partnership aimed at expanding access to advanced cancer care nationwide.

Under the agreement, Alameda Healthcare assumes full responsibility for the unit’s medical, operational, and administrative functions.

The facility will provide a wide range of cancer treatments, including radiotherapy, chemotherapy, immunotherapy, and targeted therapy, as well as advanced diagnostic tools such as PET-CT scans.

The partnership leverages the EAEA’s scientific expertise with Alameda Healthcare’s clinical and operational capabilities to create a sustainable, patient-centered treatment hub.

Investment and impact

With a total investment exceeding EGP 270 million (USD 9 million), the facility is projected to serve more than 2,000 patients annually, significantly enhancing specialized cancer treatment availability throughout Egypt.

This investment forms part of Alameda Healthcare’s broader expansion in oncology, which includes recent upgrades to radiotherapy technologies at its Dar Al Fouad facility in 6th of October and planned expansion at its new hospital in Madinaty.

A Hub for Training and Research

Beyond clinical services, the unit will function as a regional center for oncology training and research.

The facility will support medical education, specialized professional development programs, and scientific collaboration, strengthening Egypt’s capacity to develop specialized healthcare expertise.

The partnership divides responsibilities strategically: the Egyptian Atomic Energy Authority provides infrastructure, core equipment, and strategic oversight while supporting research initiatives, while Alameda Healthcare leads day-to-day operations, service development, and facility management.

Leadership perspectives

Dr. Fahad Khater, Chairman of Alameda Healthcare Group, emphasized that the partnership reflects the company’s commitment to supporting Egypt’s healthcare system and advancing quality oncology care.

He characterized the initiative as both a national responsibility and a long-term investment in strengthening healthcare infrastructure while expanding treatment availability for patients nationwide.

Dr. Amr Al Hag, Chairman of the Egyptian Atomic Energy Authority, described the collaboration as an important step in leveraging national capabilities through effective private sector engagement.

He highlighted how the partnership strengthens the integration of scientific research into medical applications while enhancing the delivery of advanced oncology services.

The partnership establishes a shared vision for creating a center of excellence in oncology treatment, training, and research.

By combining clinical expertise with sustainable practices, the initiative aims to advance innovation, broaden healthcare access, and support long-term development of Egypt’s medical sector.